Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab in refractory asthma
NCT00512863Phase 2Withdrawn
- Sponsor
- Abbott Laboratories
- Start
- Aug 2007
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 2 trial of Trudexa in asthma, sponsored by Abbott Laboratories. Planned start Aug 2007; status: withdrawn.
02
Drugs
Trudexa
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00512863.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00512863.